| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/07/2005 | EP1570852A2 Xenon for use as drug |
| 09/07/2005 | EP1570846A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 09/07/2005 | EP1569953A1 Peptide gap junction modulators |
| 09/07/2005 | EP1569928A1 Therapeutic compounds and methods |
| 09/07/2005 | EP1569897A1 Substituted tetralins and indanes |
| 09/07/2005 | EP1569692A2 Betaine and salicylic acid compositions |
| 09/07/2005 | EP1569673A1 Novel exendin agonist formulations and methods of administration thereof |
| 09/07/2005 | EP1569666A1 Herbal preparation for management of cardiovascular and neurologic disorders |
| 09/07/2005 | EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 09/07/2005 | EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 09/07/2005 | EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 09/07/2005 | EP1458717B1 Aroyl pyridinones |
| 09/07/2005 | EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/07/2005 | EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/07/2005 | EP1349850B1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 09/07/2005 | EP1328519B1 Orally active salts with tyrosine kinase activity |
| 09/07/2005 | EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 09/07/2005 | EP1294369B1 NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE |
| 09/07/2005 | EP1282621B1 Vitronectin receptor antagonists |
| 09/07/2005 | EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors |
| 09/07/2005 | EP1246642B1 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
| 09/07/2005 | EP1192132B1 Serine protease inhibitors |
| 09/07/2005 | EP1188747B1 Phenoxypropylamine compounds |
| 09/07/2005 | EP1187812B1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 09/07/2005 | EP1140026B1 Biodegradble polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 09/07/2005 | EP1073456B1 Use of osteoprotegerin for the prevention and treatment of cardiovascular diseases |
| 09/07/2005 | EP1013278B1 The extract of pine needle and the use thereof |
| 09/07/2005 | EP0888310B1 Cinnoline derivatives and use as medicine |
| 09/07/2005 | CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription |
| 09/07/2005 | CN1665922A Medium for culturing autologous human progenitor stem cells and applications thereof |
| 09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 09/07/2005 | CN1665829A Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/07/2005 | CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same |
| 09/07/2005 | CN1665812A Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 09/07/2005 | CN1665811A Carbamate-substituted pyrazolopyridines |
| 09/07/2005 | CN1665810A Inhibitors of JAK and CDK2 protein kinases |
| 09/07/2005 | CN1665809A Azaindoles |
| 09/07/2005 | CN1665807A Novel physiolgically active substances |
| 09/07/2005 | CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/07/2005 | CN1665791A Quinazoline derivatives |
| 09/07/2005 | CN1665783A Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665542A Adjuvant containing xenon |
| 09/07/2005 | CN1665541A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665540A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665538A Phamaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665536A Use of CETP inhibitors and antihypertensive agents as well as optionally HMG COA reductase inhibitors |
| 09/07/2005 | CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 09/07/2005 | CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/07/2005 | CN1665512A Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 09/07/2005 | CN1665508A Use of pyrazolo[4, 3-d]pyrimidines |
| 09/07/2005 | CN1665499A Drug composition for prevention or inhibition of advance of diabetic complication |
| 09/07/2005 | CN1665496A Use of epa and dha in secondary prevention |
| 09/07/2005 | CN1665491A Microcapsules for the delayed, controlled release of perindopril |
| 09/07/2005 | CN1665485A Compositions and methods for amelioration of human female sexual dysfunction |
| 09/07/2005 | CN1665403A Beverages containing plant sterols |
| 09/07/2005 | CN1663601A Method for preparing drug and health foodstuff to treat hypertension by brown algae plant |
| 09/07/2005 | CN1663600A Compound preparation composed of ginkgo leaf extracts and medicines promoting cerebral metabolism and its application |
| 09/07/2005 | CN1663598A Oral preparation composition for treating cerebral infarction |
| 09/07/2005 | CN1663592A Medicinal composition for treating coronary heart disease and preparation process thereof |
| 09/07/2005 | CN1663591A Hypertension-treating medicine |
| 09/07/2005 | CN1663581A Kidney-invigorating blood pressure-decreasing tea |
| 09/07/2005 | CN1663569A Fructose injection for cardiovascular medicine |
| 09/07/2005 | CN1663564A Formulation for preventing and treating thrombus disease |
| 09/07/2005 | CN1663563A Compound troxerutin and piracetam formulation and application thereof |
| 09/07/2005 | CN1218041C Lumbricus kinase of electrophoretical purity and its prepn and use |
| 09/07/2005 | CN1217953C Buxanines compounds with cardiovascular activity and cardiovascular and cerebrovascular medicine using them as active component |
| 09/07/2005 | CN1217952C Compound |
| 09/07/2005 | CN1217938C Bis-arylsulfones |
| 09/07/2005 | CN1217936C Heterocyclic compounds having sulfonamide |
| 09/07/2005 | CN1217927C Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 09/07/2005 | CN1217926C Novel vitamin D analogues |
| 09/07/2005 | CN1217920C Compounds to treat Alzheimer disease |
| 09/07/2005 | CN1217918C Aminocyclohexyl ether compounds and uses thereof |
| 09/07/2005 | CN1217699C Preventives or remedies for arrhythmia |
| 09/07/2005 | CN1217692C Chinese herbal medicine for treating cardio-cerebral vascular disease and health care and its preparing method |
| 09/07/2005 | CN1217691C Chinese medicinal composition for treating piles and preparing method thereof |
| 09/07/2005 | CN1217689C Houpo Huanglian Ye (magnolia coptis liguor) for treating piles |
| 09/07/2005 | CN1217683C Prescription of lotion for treating pile and fistula and its preparing process |
| 09/07/2005 | CN1217677C Medicine for treating rheumatic heart disease |
| 09/07/2005 | CN1217673C Chinese medicine for fuming and washing piles and its preparation process |
| 09/07/2005 | CN1217584C Effervescent green tea extract formulation |
| 09/06/2005 | US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties |
| 09/06/2005 | US6939989 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/06/2005 | US6939897 Method and composition for inhibiting arteriosclerosis |
| 09/06/2005 | US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/06/2005 | US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 09/06/2005 | US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders |
| 09/06/2005 | US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 09/06/2005 | US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |
| 09/06/2005 | US6939865 Cardiovascular disorders; antiarrhythmia agents |
| 09/06/2005 | US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 09/06/2005 | US6939568 Hydrated dressing containing metal microbiocide |
| 09/06/2005 | US6939565 Protease inhibitors of the coagulation cascade isolated from Dysidea sponges |
| 09/06/2005 | US6939376 Drug-delivery endovascular stent and method for treating restenosis |
| 09/06/2005 | CA2250395C Eprosartan dihydrate and a process for its production and formulation |